AWH Announces $49 Million Sale-Leaseback of Massachusetts Facility to Innovative Industrial Properties, Inc (IIP)

Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced that it closed on the acquisition of a property with Ascend Wellness Holdings (AWH), a Salveo Capital portfolio company. Assuming full reimbursement for the tenant improvements, IIP’s total investment in the property will be $49.0 million. This Massachusetts property represents IIP’s third real estate transaction with AWH.

Read More
Sean Doyle
An industry already in need of “drastic changes”

“I see a lot of new companies that are well-positioned that focus on cloud-centric computing, remote telehealth services, online commerce fulfillment, and anything to do with the last mile for cannabis transactions,” said cannabis investor Michael Gruber of Chicago-based Salveo Capital. “I also continue to believe that now through the end of the year will be some of the best opportunities we’ve seen for troubled and distressed companies. The bad overall situation in many ways serves as cover for companies that already needed to make drastic changes.”

Read More
Sean Doyle
Comparable to Organic: How This California Company Aims to Certify Cannabis

In 2010, Ian Rice co-founded SC Laboratories, a Salveo Capital portfolio company, one of the first cannabis testing labs in the world, and helped develop the cannabis industry’s first testing standards. In 2016, Rice and his partners at SC Labs launched Envirocann, a third-party certification organization, focused on the quality assurance and quality control of cannabis products. Through on-site inspections and lab testing, Envirocann verifies and subsequently certifies that best practices are used to grow and process cannabis, while confirming environmental sustainability and regulatory compliance.

Read More
Sean Doyle
3 Companies Leading Tech Innovation In The Cannabis Sector

Salveo Capital portfolio company Fyllo has been one of the most active companies in the cannabis industry and is an opportunity that we have become increasingly excited about. We believe that Fyllo is led by one of the most impressive management teams in the cannabis space and find this to be an important aspect of the story. The strength of the management team has played an important role in its ability to raise capital and make accretive acquisitions.

Read More
Sean Doyle
How Front Range Biosciences Leverages the Power of Partnerships

In August 2019, the team at Front Range Biosciences (FRB), a Salveo Capital portfolio company, saw a boom in growth when the Lafayette, Colo.-based hemp genomics business acquired the entire R&D team at Steep Hill. Heading into 2020, the company shows no signs of slowing down. In January alone, FRB announced four partnerships with different distributors that can both share the company’s genetics and also help build relationships with farmers across the country.

Read More
Sean Doyle
7 Salveo Capital portfolio companies listed on Business Insiders' 15 buzziest cannabis startups to bet on in 2020

"We had been a prior investor, but become more deeply invested in Ascend Wellness Holdings in 2019 as we were impressed with management's ability to acquire key assets in attractive state markets, and with their ability to manage the complicated process of getting through permitting and opening stores. Fast forward to today, we are very excited with the company's ability to have some of the first recreational stores in both Illinois and Michigan and where both stores are doing extremely well, and with the company getting recent approval for the first retail store within Boston limits in Massachusetts." — Michael Gruber of Salveo Capital. Please see full article for additional commentary from Michael Gruber.

Read More
Sean Doyle
KELSIE BIOTECH BRINGS ON BEN KAANTA AS CEO

Jeffrey Howard, a principal at Salveo Capital which led Kelsie’s recent funding, had this to say: “After a thorough and lengthy CEO search, we couldn’t be more delighted to bring Ben in to lead the team at KelSie Biotech. As KelSie’s SUM Microdose product line continues its aggressive expansion, Ben’s executive-level cannabis experience and existing operational skillset are ideal for this phase of KelSie’s growth.”

Read More
Sean Doyle
Front Range Biosciences Continues to Expand Hemp Sales and Distribution Network with Coastal Organix and Alterra Hemp Partnerships

Salveo Capital portfolio company Front Range Biosciences® ("FRB"), announced a continued expansion of distribution partnerships with Coastal Organix and Alterra. The announcement expands FRB's network of hemp distributors, especially in the southeast region and brings a stronger, more diverse 2020 pipeline that includes CBG varieties.

Read More
Sean Doyle
Fyllo Acquires CannaRegs To Create Data Powerhouse

Cannabis marketing tech firm Fyllo, a Salveo Capital portfolio company, has acquired cannabis regulatory tech firm CannaRegs. CannaRegs distinguished itself for the company’s ability to drill down into local cannabis regulations, which can differ between the municipality, county and state levels of oversite.

Read More
Sean Doyle
VC investing in cannabis surged above $2 billion in 2019, but a year-end slowdown raises questions about 2020

"The first two quarters of 2020 will be a cautious period to see how things develop," said Michael Gruber, managing partner at the investment firm Salveo Capital. "But it is clear that there will be a lot of consolidation, and there will be a good number of companies that effectively disappear or got absorbed by others as they will not have access to capital." Gruber said he expects there will be a return to more sensible valuations and a significant increase investments in the second half of 2020.

Read More
Sean Doyle
Here are the top 14 venture capital firms making deals in the cannabis industry, and where they're looking to place their next bets

Cannabis-focused Salveo Capital has made a total of 35 investments since it launched in 2016. Salveo Capital Managing Partner Michael C. Gruber told Business Insider the company is interested in investing in several areas in 2020, such as lab testing and other compliance solutions, brands, international opportunities, distribution and e-commerce, and troubled or distressed firms.

Read More
Sean Doyle